Servier Archives - Regulatory Professionals

January 30, 2012

Servier Cleared Of Deception Charges From EU Regulators

The European Commission has dropped the charges against Servier, a French independent pharmaceutical company, which accused the French company of providing “misleading and incorrect information” as part of a high-profile review of the pharmaceuticals sector and practices to postpone the market entry of generic drugs. In July 2010, the European Commission sent a ‘statement of

Written by Stephen Smith

October 11, 2011

Servier Signs Agreements with Hybrigenics and Cortex

Servier, the largest French privately-owned pharmaceutical company, has linked up with fellow French firm Hybrigenics to discover first-in-class drugs for a selection of diseases, notably cancer. The companies have signed a licence and research collaboration agreement in the field of deubiquitinating enzymes (DUBs) to be applied to oncology, neurology, psychiatry, rheumatology, ophthalmology, diabetes and cardiovascular

Regulatory Professionals

Regulatory Affairs Recruitment

Servier

Servier Cleared Of Deception Charges From EU Regulators

Servier Signs Agreements with Hybrigenics and Cortex

Like to Talk to a Consultant?